Reappraising the role of thyroid scintigraphy in the era of TIRADS: A clinically-oriented viewpoint.
Journal
Endocrine
ISSN: 1559-0100
Titre abrégé: Endocrine
Pays: United States
ID NLM: 9434444
Informations de publication
Date de publication:
16 Apr 2024
16 Apr 2024
Historique:
received:
29
02
2024
accepted:
06
04
2024
medline:
16
4
2024
pubmed:
16
4
2024
entrez:
16
4
2024
Statut:
aheadofprint
Résumé
Thyroid nodules (TNs) are a common entity, with the majority being benign. Therefore, employing an accurate rule-out strategy in clinical practice is essential. In the thyroid field, the current era is significantly marked by the worldwide diffusion of ultrasound (US)-based malignancy risk stratification systems of TN, usually reported as Thyroid Imaging Reporting And Data System (TIRADS). With the advent of US (and later TIRADS), the role of thyroid scintigraphy (TS) in clinical practice has gradually diminished. The authors of the present paper believe that the role of TS should be reappraised, also considering its essential role in detecting autonomously functioning thyroid nodules and its limited contribution to detecting thyroid cancers. Thus, this document aims to furnish endocrinologists, radiologists, surgeons, and nuclear medicine physicians with practical information to appropriately use TS.
Identifiants
pubmed: 38625504
doi: 10.1007/s12020-024-03825-0
pii: 10.1007/s12020-024-03825-0
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
L. Hegedüs, Clinical practice. The thyroid nodule. N Engl J Med 351, 1764–1771 (2004). https://doi.org/10.1056/NEJMcp031436)
M. Grussendorf, I. Ruschenburg, G. Brabant, Malignancy rates in thyroid nodules: a long-term cohort study of 17,592 patients. Eur. Thyroid J. 11, e220027 (2022). https://doi.org/10.1530/ETJ-22-0027
doi: 10.1530/ETJ-22-0027
pubmed: 35635802
pmcid: 9254276
WHO Classification of Tumours Editorial Board: Endocrine and Neuroendocrine tumours, vol. 8. 5th edn. (International Agency for Research on Cancer, Lyon, France, 2022). https://tumourclassification.iarc.who.int
F.N. Tessler, W.D. Middleton, E.G. Grant et al. ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee. J. Am. Coll. Radio. 14, 587–595 (2017). https://doi.org/10.1016/j.jacr.2017.01.046
doi: 10.1016/j.jacr.2017.01.046
G. Russ, S.J. Bonnema, M.F. Erdogan et al. European Thyroid Association Guidelines for Ultrasound Malignancy Risk Stratification of Thyroid Nodules in Adults: The EU-TIRADS. Eur. Thyroid J. 6, 225–237 (2017). https://doi.org/10.1159/000478927
doi: 10.1159/000478927
pubmed: 29167761
pmcid: 5652895
E.J. Ha, S.R. Chung, D.G. Na et al. 2021 Korean Thyroid Imaging Reporting and Data System and Imaging-Based Management of Thyroid Nodules: Korean Society of Thyroid Radiology Consensus Statement and Recommendations. Korean J. Radio. 22, 2094–2123 (2021). https://doi.org/10.3348/kjr.2021.0713
doi: 10.3348/kjr.2021.0713
P. Trimboli, M. Castellana, A. Piccardo et al. The ultrasound risk stratification systems for thyroid nodule have been evaluated against papillary carcinoma. A meta-analysis. Rev. Endocr. Metab. Disord. 22, 453–460 (2021). https://doi.org/10.1007/s11154-020-09592-3
doi: 10.1007/s11154-020-09592-3
pubmed: 32959174
C. Durante, L. Hegedüs, D.G. Na et al. International Expert Consensus on US Lexicon for Thyroid Nodules. Radiology 309, e231481 (2023). https://doi.org/10.1148/radiol.231481 . PMID: 37906014
doi: 10.1148/radiol.231481
pubmed: 37906014
G.B. Coura-Filho, M. Torres Silva de Oliveira, A.L. Morais de Campos, (2022). Thyroid Scintigraphy in the Workup of a Thyroid Nodule. In: Nuclear Medicine in Endocrine Disorders. Springer, Cham. https://doi.org/10.1007/978-3-031-13224-7_7
S. Schenke, P. Seifert, M. Zimny et al. Risk stratification of thyroid nodules using the Thyroid Imaging Reporting and Data System (TIRADS): the omission of thyroid scintigraphy increases the rate of falsely suspected lesions. J. Nucl. Med. 60, 342–347 (2019). https://doi.org/10.2967/jnumed.118.211912
doi: 10.2967/jnumed.118.211912
pubmed: 30097501
M. Castellana, C. Virili, G. Paone et al. Ultrasound systems for risk stratification of thyroid nodules prompt inappropriate biopsy in autonomously functioning thyroid nodules. Clin. Endocrinol. 93, 67–75 (2020). https://doi.org/10.1111/cen.14204
doi: 10.1111/cen.14204
A. Kyrilli, N. Tacelli, L. Russo et al. Autonomously functioning thyroid nodules present intermediate malignancy risk according to European Thyroid Imaging Reporting and Data System (EU-TIRADS) and yield indeterminate cytology results. Eur. Thyroid J. 12, e230135 (2023). https://doi.org/10.1530/ETJ-23-0135
doi: 10.1530/ETJ-23-0135
pubmed: 37992294
pmcid: 10762547
K. Yuang, H. Al-Bahadili, A. Chang, An unexpected finding of poorly differentiated thyroid carcinoma in a toxic thyroid nodule. JCEM Case Rep. 1, luad052 (2023). https://doi.org/10.1210/jcemcr/luad052
doi: 10.1210/jcemcr/luad052
pubmed: 37908574
pmcid: 10580452
M.S. Goonoo, M.F. Arshad, F. Tahir et al. Toxic adenoma: to biopsy or not to biopsy? Ann. R. Coll. Surg. Engl. 103, e319–e323 (2021). https://doi.org/10.1308/rcsann.2021.0008
doi: 10.1308/rcsann.2021.0008
pubmed: 34435917
pmcid: 10335139
B.R. Haugen, E.K. Alexander, K.C. Bible et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26, 1–133 (2016). https://doi.org/10.1089/thy.2015.0020
doi: 10.1089/thy.2015.0020
pubmed: 26462967
pmcid: 4739132
C. Durante, L. Hegedüs, A. Czarniecka et al. 2023 European Thyroid Association Clinical Practice Guidelines for thyroid nodule management. Eur. Thyroid J. 12, e230067 (2023). https://doi.org/10.1530/ETJ-23-0067
doi: 10.1530/ETJ-23-0067
pubmed: 37358008
pmcid: 10448590
L. Giovanella, A.M. Avram, I. Iakovou et al. EANM practice guideline/SNMMI procedure standard for RAIU and thyroid scintigraphy. Eur. J. Nucl. Med Mol. Imaging 46, 2514–2525 (2019). https://doi.org/10.1007/s00259-019-04472-8
doi: 10.1007/s00259-019-04472-8
pubmed: 31392371
R. Cesareo, A. Palermo, V. Pasqualini et al. Radiofrequency ablation on autonomously functioning thyroid nodules: a critical appraisal and review of the literature. Front Endocrinol. 11, 317 (2020). https://doi.org/10.3389/fendo.2020.00317
doi: 10.3389/fendo.2020.00317
A. Belfiore, L. Sava, F. Runello et al. Solitary autonomously functioning thyroid nodules and iodine deficiency. J. Clin. Endocrinol. Metab. 56, 283–7 (1983). https://doi.org/10.1210/jcem-56-2-283 . PMID: 6822638
doi: 10.1210/jcem-56-2-283
pubmed: 6822638
A. Piccardo, F. Fiz, G. Bottoni et al. The FDG pattern of autonomously functioning thyroid nodules correlates with thyroid-stimulating hormone and histopathology. Clin. Nucl. Med 48, 119–125 (2023). https://doi.org/10.1097/RLU.0000000000004396
doi: 10.1097/RLU.0000000000004396
pubmed: 36260757
G. Mauri, E. Papini, S. Bernardi et al. Image-guided thermal ablation in autonomously functioning thyroid nodules. A retrospective multicenter three-year follow-up study from the Italian Minimally Invasive Treatment of the Thyroid (MITT) Group. Eur. Radio. 32, 1738–1746 (2022). https://doi.org/10.1007/s00330-021-08289-8
doi: 10.1007/s00330-021-08289-8
D.S. Ross, H.B. Burch, D.S. Cooper et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid 26, 1343–1421 (2016). https://doi.org/10.1089/thy.2016.0229 . Erratum in: Thyroid. 2017 Nov;27(11):1462
doi: 10.1089/thy.2016.0229
pubmed: 27521067
S.Y. Lee, E.N. Pearce, Hyperthyroidism: A Review. JAMA 330, 1472–1483 (2023). https://doi.org/10.1001/jama.2023.19052
doi: 10.1001/jama.2023.19052
pubmed: 37847271
C. Cerci, S.S. Cerci, E. Eroglu et al. Thyroid cancer in toxic and non-toxic multinodular goiter. J. Postgrad. Med 53, 157–60 (2007). https://doi.org/10.4103/0022-3859.33855
doi: 10.4103/0022-3859.33855
pubmed: 17699987
B. Noto, M. Eveslage, M. Pixberg et al. Prevalence of hyperfunctioning thyroid nodules among those in need of fine needle aspiration cytology according to ATA 2015, EU-TIRADS, and ACR-TIRADS. Eur. J. Nucl. Med Mol. Imaging 47, 1518–1526 (2020). https://doi.org/10.1007/s00259-020-04740-y
doi: 10.1007/s00259-020-04740-y
pubmed: 32152666
pmcid: 7188716
E. Reschini, C. Ferrari, M. Castellani et al. The trapping-only nodules of the thyroid gland: prevalence study. Thyroid 16, 757–62 (2006). https://doi.org/10.1089/thy.2006.16.757
doi: 10.1089/thy.2006.16.757
pubmed: 16910877
P. Trimboli, G. Paone, G. Treglia et al. Fine-needle aspiration in all thyroid incidentalomas at 18 F-FDG PET/CT: Can EU-TIRADS revise the dogma? Clin. Endocrinol. 89, 642–648 (2018). https://doi.org/10.1111/cen.13819
doi: 10.1111/cen.13819
A. Belfiore, G.L. La Rosa, G.A. La Porta et al. Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. Am J Med 93((Oct 4), 363–9 (1992). https://doi.org/10.1016/0002-9343(92)90164-7
L.M. Hurtado-López, C. Martínez-Duncker, Negative MIBI thyroid scans exclude differentiated and medullary thyroid cancer in 100% of patients with hypofunctioning thyroid nodules. Eur. J. Nucl. Med Mol. Imaging 34, 1701–3 (2007). https://doi.org/10.1007/s00259-007-0490-6
doi: 10.1007/s00259-007-0490-6
pubmed: 17581750
S.J. Kim, S.W. Lee, S.Y. Jeong et al. Diagnostic performance of Technetium-99m Methoxy-Isobutyl-Isonitrile for differentiation of malignant thyroid nodules: a systematic review and meta-analysis. Thyroid 28, 1339–1348 (2018). https://doi.org/10.1089/thy.2018.0072
doi: 10.1089/thy.2018.0072
pubmed: 30129898
E.J. de Koster, L.F. de Geus-Oei, O.M. Dekkers et al. Diagnostic utility of molecular and imaging biomarkers in cytological indeterminate thyroid nodules. Endocr. Rev. 39, 154–191 (2018). https://doi.org/10.1210/er.2017-00133
doi: 10.1210/er.2017-00133
pubmed: 29300866
A. Piccardo, M. Puntoni, G. Treglia et al. Thyroid nodules with indeterminate cytology: prospective comparison between 18F-FDG-PET/CT, multiparametric neck ultrasonography, 99mTc-MIBI scintigraphy and histology. Eur. J. Endocrinol. 174, 693–703 (2016). https://doi.org/10.1530/EJE-15-1199
doi: 10.1530/EJE-15-1199
pubmed: 26966173
A. Piccardo, M. Puntoni, M. Dezzana et al. Indeterminate thyroid nodules. The role of 18F-FDG PET/CT in the “era” of ultrasonography risk stratification systems and new thyroid cytology classifications. Endocrine 69, 553–561 (2020). https://doi.org/10.1007/s12020-020-02239-y
doi: 10.1007/s12020-020-02239-y
pubmed: 32124261
M. Castellana, P. Trimboli, A. Piccardo et al. Performance of 18F-FDG PET/CT in selecting thyroid nodules with indeterminate fine-needle aspiration cytology for surgery. a systematic review and a meta-analysis. J. Clin. Med 8, 1333 (2019). https://doi.org/10.3390/jcm8091333
doi: 10.3390/jcm8091333
pubmed: 31466411
pmcid: 6780221
W. Qichang, S. Jinming, L. Lu et al. Comparison of 18F-FDG-PET and 18F-FDG-PET/CT for the diagnostic performance in thyroid nodules with indeterminate cytology: A meta-analysis. Med. (Baltim.) 99, e20446 (2020). https://doi.org/10.1097/MD.0000000000020446
doi: 10.1097/MD.0000000000020446
G.L. Dillehay, Choosing wisely in nuclear medicine and molecular imaging. J. Nucl. Med 54, 17N–18N (2013)
pubmed: 23457355